·First generic drug in China ·Winner of multiple industry awards, including "Excellent Product Brand in the Cardiovascular and Cerebrovascular Category" from the China Chemical and Pharmaceutical Industry Association ·Recommended by multiple authoritative domestic and international guidelines, including ISH, JSH, and ESC ·Serves over 4 million hypertension patients annually

*For contraindications and adverse reactions, please see the package insert

·A glucagon-like peptide-1 (GLP-1) receptor agonist with evidence of both cardiovascular and renal benefits ·Recommended as a first-line treatment in the "2024 China Diabetes Prevention and Treatment Guidelines" for patients with type 2 diabetes mellitus who are overweight or have obesity, with established atherosclerotic cardiovascular disease (ASCVD) or high risk, or with chronic kidney disease (CKD)

*For contraindications and adverse reactions, please see the package insert

·The only isotonic, non-ionic iodinated contrast agent currently in clinical use ·Used for angiocardiogram, cerebral angiogram, peripheral arteriogram, abdominal angiogram, urogram, venogram, and CT-enhanced examination in adults

*For contraindications and adverse reactions, please see the package insert

·A Ringer's solution that approximates human extracellular fluid ·The first of its generic name to pass the consistency evaluation ·Widely applicable in anesthesiology, ICU, surgery, and emergency departments ·Benefiting millions of patients

*For contraindications and adverse reactions, please see the package insert

·A potent lipid-modulating drug, first marketed as a generic in China ·Among the first batch to pass the generic drug consistency evaluation ·Winner of multiple industry awards, including "Excellent Product Brand in the Lipid-Regulating Category" from the China Chemical and Pharmaceutical Industry Association

*For contraindications and adverse reactions, please see the package insert

·A fully human monoclonal antibody that targets and inhibits tumour necrosis factor-alpha ·Approved for multiple indications, including rheumatoid arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease ·Multiple clinical trials have shown that Adalimumab can effectively alleviate disease activity, improve joint function and skin lesion symptoms, and achieve long-term disease control in some patients ·Pre-filled syringe design simplifies operation and improves medication adherence

*For contraindications and adverse reactions, please see the package insert

·Esomeprazole is the world's first optical isomer proton pump inhibitor ·Multi-unit pellet system (MUPS) formulation meets antacid needs ·Indications cover GERD, eradication of Helicobacter pylori in combination therapy, and NSAID-associated gastric ulcers

*For contraindications and adverse reactions, please see the package insert

·Canagliflozin is the first hypoglycemic drug proven to have hard renal endpoint benefits, along with hard cardiovascular endpoint benefits ·In the "2024 China Diabetes Prevention and Treatment Guidelines", Canagliflozin is recommended as a first-line therapeutic drug for patients with type 2 diabetes mellitus with established ASCVD or high risk, with heart failure (HF), or with CKD

*For contraindications and adverse reactions, please see the package insert

·A sodium-glucose co-transporter-2 inhibitor (SGLT-2i) for the treatment of type 2 diabetes mellitus ·In the "2024 China Diabetes Prevention and Treatment Guidelines", Empagliflozin is recommended as a first-line therapeutic drug for patients with type 2 diabetes mellitus with established ASCVD or high risk, with HF, or with CKD

*For contraindications and adverse reactions, please see the package insert